Boston Partners Trims Holdings in The Allstate Co. (NYSE:ALL)

Boston Partners decreased its position in The Allstate Co. (NYSE:ALL - Free Report) by 1.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 347,761 shares of the insurance provider's stock after selling 4,489 shares during the period. Boston Partners owned about 0.13% of Allstate worth $67,025,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. FSA Wealth Management LLC purchased a new stake in Allstate in the third quarter worth $26,000. Twin Tree Management LP purchased a new position in shares of Allstate in the 4th quarter worth about $27,000. Vision Financial Markets LLC purchased a new position in shares of Allstate in the 4th quarter worth about $29,000. Hopwood Financial Services Inc. purchased a new position in shares of Allstate in the 4th quarter worth about $29,000. Finally, Peoples Bank KS purchased a new position in shares of Allstate in the 4th quarter worth about $49,000. Institutional investors own 76.47% of the company's stock.

Allstate Stock Down 1.7 %

Shares of ALL traded down $3.58 during midday trading on Friday, reaching $206.60. 2,886,777 shares of the stock were exchanged, compared to its average volume of 1,504,505. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $54.76 billion, a P/E ratio of 12.16, a PEG ratio of 1.01 and a beta of 0.47. The Allstate Co. has a 52 week low of $156.66 and a 52 week high of $212.91. The company's 50 day moving average is $193.75 and its two-hundred day moving average is $193.07.

Remove Ads

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, topping analysts' consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. On average, sell-side analysts anticipate that The Allstate Co. will post 18.74 earnings per share for the current year.

Allstate announced that its board has approved a share repurchase plan on Wednesday, February 26th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the insurance provider to purchase up to 3% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board believes its stock is undervalued.

Allstate Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 10th will be paid a dividend of $1.00 per share. This is a boost from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.94%. The ex-dividend date is Monday, March 10th. Allstate's dividend payout ratio is 23.54%.

Insider Buying and Selling

In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at approximately $3,378,990.95. This trade represents a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.80% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Barclays reduced their price objective on Allstate from $187.00 to $183.00 and set an "underweight" rating for the company in a report on Monday, January 6th. Wells Fargo & Company boosted their price target on Allstate from $186.00 to $187.00 and gave the stock an "equal weight" rating in a report on Tuesday, January 14th. Piper Sandler upped their price objective on Allstate from $206.00 to $244.00 and gave the stock an "overweight" rating in a report on Tuesday, November 26th. Keefe, Bruyette & Woods boosted their target price on Allstate from $235.00 to $240.00 and gave the company an "outperform" rating in a research report on Tuesday, February 11th. Finally, Argus raised Allstate from a "hold" rating to a "buy" rating in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, one has issued a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $217.94.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.